BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv6.18.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180719
DTEND;VALUE=DATE:20180821
DTSTAMP:20180719T071548Z
CREATED:20180719T071548Z
LAST-MODIFIED:20180719T071548Z
UID:20433-1531958400-1534809599@ces.b2sg.org
SUMMARY:Post-Doctoral Research Fellow
DESCRIPTION:A postdoctoral position in the laboratory of Dr. Gavin Ha and the Computational Biology Program is available immediately. We are seeking a highly motivated individual who is interested in studying cancer and understanding the genetic and epigenetic basis driving cancer progression. Candidates who are excited about large/complex ‘omics’ data analysis and methods development for cancer research are encouraged to apply. The position has a duration of at least one year with a competitive salary and great benefits. \n\nThe Ha lab is establishing a research program that uses new DNA sequencing technologies to study cancer genomes. The lab is also focused on research involving liquid biopsies\, such as cell-free DNA\, and developing new computational approaches to leverage these data for genome discovery and cancer burden monitoring. The research interests/projects in the Ha lab include: \n\nAnalysis of cancer genomes to understand tumor progression/evolution\, metastatic disease\, non-coding genome alterations\, copy number alterations\, genome rearrangements and 3D structure\, mutational signatures\nDevelopment of novel computational algorithms for long-range (linked-reads or long-reads) whole genome sequencing of tumors\nAnalysis of linked-read whole genome sequencing data to uncover novel alterations driving metastatic prostate cancer\nAnalysis of cell-free DNA in plasma samples from patients under treatment\nDevelopment and analysis of sensitive approaches to detect tumor-derived DNA in cell-free DNA from patient blood plasma\nThe lab will work with collaborators to validate results using functional experiments\nFor examples of recent studies\, see PMID:29909985\, PMID:29109393\, PMID:25060187\n(please use the apply button below)\n\n\nCandidates with strong interest and/or expertise in any of these research areas are highly encouraged to apply \n\nCancer genomics\, liquid biopsies\, tumor evolution/heterogeneity\nApplication of statistical modeling\, algorithm design\, artificial intelligence to study cancer and genetics\nAnalysis of large\, complex genome\, epigenome\, or transcriptome data\n\n\nQualifications:\nApplicants must have a PhD in one of these disciplines: Computational biology\, bioinformatics\, computer science\, data science\, statistics\, computer/electrical engineering\, physics\, or other related fields \nApplicants should have some of the following skills and experience: \n\nWork well in team environments; strong communication/organization skills; detail-oriented\nStrong programming experience (R\, Python\, Matlab\, Java\, C/C++\, Perl or other languages for research)\nExperience with high performance computing environments and cloud computing environments is a plus\nExperience with analyzing sequencing data is considered a strong asset\nApplicants must have a demonstrated publication track record.\nA background in cancer biology (esp in prostate or breast cancer) is considered a strong asset.\n\n\nTo apply\, please submit your application with the following: \n\na several paragraph statement of research interests\nCV\nnames and email addresses of three references\ntwo representative publications or preprints (if available)
URL:https://ces.b2sg.org/event/hutch-18jul18/
LOCATION:Fred Hutchinson Cancer Research Center
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/fred_hutch.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180720
DTEND;VALUE=DATE:20180822
DTSTAMP:20180720T083943Z
CREATED:20180720T083943Z
LAST-MODIFIED:20180720T083943Z
UID:20435-1532044800-1534895999@ces.b2sg.org
SUMMARY:Post-doctoral Fellow | Molecular Biology
DESCRIPTION:About City of Hope \nCity of Hope\, an innovative biomedical research\, treatment and educational institution with over 5\,000 employees\, is dedicated to the prevention and cure of cancer and other life-threatening diseases and guided by a compassionate\, patient-centered philosophy. \nFounded in 1913 and headquartered in Duarte\, California\, City of Hope is a remarkable non-profit institution\, where compassion and advanced care go hand-in-hand with excellence in clinical and scientific research. City of Hope is a National Cancer Institute designated Comprehensive Cancer Center and a founding member of the National Comprehensive Cancer Network\, an alliance of the nation’s 20 leading cancer centers that develops and institutes standards of care for cancer treatment. \nRequisition number 14254 \nPosition Summary and Key Responsibilities:\nPostdoctoral Research Fellow\, Dr. David Chen Laboratory – Department of Systems Biology\, Beckman Research Institute Dr. David Chen’s laboratory in Systems Biology is focused on the epigenetic mechanisms underlying the therapeutic resistance in cancers. This laboratory is skilled in high-throughput CRISPR genetic screens for de novo therapeutic target discovery. They also utilize next-generation sequencing (NGS) for epigenomic and transcriptomic analyses (ChIPseq\, ATACseq\, RNAseq\, etc.)\, and the patient-derived xenograft (PDX) models for in vivo therapeutic efficacy assessments. In addition\, Dr. Chen’s laboratory is involved in cutting-edge technology development including high-density CRISPR protein scan\, and precision epigenome editing.Dr. Chen received his postdoctoral training from Dr. Scott Armstrong in Harvard Medical School. His laboratory in City of Hope currently consists 3 postdocs\, 1 computational biologist\, and 1 technician. The lab is well funded by a 5-year institutional start-up\, an NIH K99/R00 Award\, and an ASH Scholar Award. An additional NIH R01 Award (scored top 3%) is expected to start in 2019. \nQualifications:\nPhD in cell or molecular biology\, genuine enthusiasm for science\, willingness to think beyond established concepts and to try and learn new experimental and analysis tools. The lab takes a team science approach\, so being a nice person and enjoyable to work with is important as well. \nYour application should include in one single PDF :\nCV\, brief motivation statement\, coordinates of three references \nExperience:\nMammalian cell culture\, cell biology (required); Cancer/leukemia-related studies (preferred); Molecular biology\, cloning\, biochemistry (preferred); Animal model studies (preferred); High-throughput sequencing and computational analysis (preferred) 
URL:https://ces.b2sg.org/event/hope-19jul18/
LOCATION:City of Hope\, 1500 East Duarte Road\, Duarte\, 91010\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/02/City-of-hope.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180721
DTEND;VALUE=DATE:20180723
DTSTAMP:20180505T183814Z
CREATED:20180502T231455Z
LAST-MODIFIED:20180505T183814Z
UID:19975-1532131200-1532303999@ces.b2sg.org
SUMMARY:Chromatin: Plasticity and Genome Regulation in Physiology and Disease
DESCRIPTION:The Gordon Research Seminar on Chromatin Structure and Function is a unique forum for graduate students\, post-docs\, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas. \nThe inaugural 2018 Gordon Research Seminar in Chromatin Structure and Function is a meeting for young scientists and established investigators presenting leading-edge research and innovative ideas. The meeting will explore the various aspects of chromatin biology including the hierarchies of chromatin structure\, visualization and engineering of chromatin\, regulation of genome functions and connections between epigenetic modifications and cellular metabolism in the context of development and human disease. A wide range of approaches including genome-wide chromatinomics\, structural biology\, proteomics\, computational modeling and high resolution microscopy will be highlighted in the seminar. \nThe main goal of the Chromatin Structure and Function GRS is to provide unique opportunities for younger attendees to scientifically interact with their peers as well as with established investigators in the field. Following the historic footsteps of the associated GRC\, the Chromatin Structure and Function GRS fosters the exchange of novel ideas\, diverse interactions and long-lasting collaborations. Early-stage scientists will have the opportunity to present their work and obtain feedback from colleagues and experienced scientists\, enabling them to build on their work and potentially explore novel ideas. In addition\, there will be a session dedicated to career advising for graduate students as well as postdocs. Attendees will have a chance to hear about the experiences of scientists at various career stages and explore additional opportunities for professional development. We aim to make the GRS a long-lasting component of the Chromatin Structure and Function GRC and to attract enthusiastic and talented young researchers with eagerness to expand their scientific inquiry. We expect the scientific interactions at the GRS to carry over to the main conference to make it an even more enriching experience for all attendees. \nApplication Instructions\nThe seminar will feature approximately 10 talks and 2 poster sessions. All attendees are expected to actively participate in the GRS\, either by giving an oral presentation or presenting a poster. Therefore\, all applications must include an abstract. \nThe seminar chair will select speakers from abstracts submitted by April 21\, 2018. Those applicants who are not chosen for talks and those who apply after the deadline to be considered for an oral presentation will be expected to present a poster. In order to participate\, you must submit an application by the date indicated in the Application Information section above. \nProgram Format\nGordon Research Seminars are 2-day meetings which take place on the Saturday and Sunday just prior to the start of the associated GRC. The GRS opens with a 1-hour introductory session on Saturday afternoon\, followed by a poster session\, dinner and a 2-hour session in the evening. Sunday morning begins with breakfast and is followed by another 2-hour session\, a second poster session\, and lunch. A final 1-hour session takes place just after lunch\, and the associated GRC begins later that evening. \nApplications for this meeting must be submitted by June 23\, 2018. Please apply early\, as some meetings become oversubscribed (full) before this deadline. If the meeting is oversubscribed\, it will be stated here. Note: Applications for oversubscribed meetings will only be considered by the conference chair if more seats become available due to cancellations. \nGRS Speaker Abstract Deadline: Although applications will be accepted until the date noted above\, any applicants who wish to be considered for an oral presentation should submit their application by April 21\, 2018. Please refer to the application instructions in the Conference Description section below for more details (if available). \nAn outline of the program components for this GRS is displayed below. The seminar chair is currently developing their detailed program schedule\, which will include the speakers they select from submitted abstracts\, in addition to any additional components outlined below. The detailed program will be available by May 21\, 2018. Please check back for updates. \n\nKeynote Speaker\n\n\n\nPetra Hajkova (MRC London Institute of Medical Sciences\, United Kingdom)\n\n\n\nSpeakers\n\n\n\nTo Be Selected from Submitted Abstracts\n\n\n\nDiscussion Leaders\n\n\n\nAna Pombo (Berlin Institute for Medical Systems Biology\, Germany)\nLars Jansen (Instituto Gulbenkian de Ciência\, Fundação Calouste Gulbenkian\, Portugal)\nAlistair Boettiger (Stanford University School of Medicine\, USA)\n\n\n\n\nAdditional Discussion Leaders May Be Selected from Submitted Abstracts\n\n\n\nMentorship Component\n\n\n“The Next Chapter in Chromatin Biology”
URL:https://ces.b2sg.org/event/grs-21jul18/
LOCATION:Grand Summit Hotel at Sunday River\, 97 Summit Road\, Newry\, ME\, United States
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/05/grs_logo_rgb-e1525287092671.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180722
DTEND;VALUE=DATE:20180728
DTSTAMP:20180507T193523Z
CREATED:20180502T143150Z
LAST-MODIFIED:20180507T193523Z
UID:19965-1532217600-1532735999@ces.b2sg.org
SUMMARY:Chromatin Encounters: Shaping Genome Architecture and Function
DESCRIPTION:The 2018 Gordon Conference on Chromatin Structure and Function will bring together leading experts and newcomers to the field\, to present and discuss their newest research on chromatin\, its complex interactions\, and its regulatory power in shaping genome architecture and function. Technologies to visualize and map chromatin at all levels are proceeding at a rapid pace. The meeting will highlight how chromatin structures\, ranging from the nucleosome – the “building block” of chromatin – up to the dynamic three-dimensional spatial organization of the chromosome\, are assembled\, maintained\, and altered\, and how this ultimately controls genome functions. \nInterconnected questions at the frontier of the field will be addressed – how does the nucleosome interact with other nuclear factors\, how is chromatin assembled\, disassembled\, and maintained in a dynamic state\, what is the molecular basis for the crosstalk between epigenetic modifications and metabolism\, and how does dysfunction of any of these processes result in disease. \nPresentations will encompass a wide variety of innovative technical approaches – from Angstrom level description of chromatin components at all organizational levels to the visualization of micron-scale structures by light microscopy\, and the mapping of chromatin states genome-wide at unprecedented resolution. There will be a focus on new methods to determine chromatin dynamics and the relationships between chromatin structure and function\, and on adapting these to the level of single molecules and single cells. \nApplications for this meeting must be submitted by June 24\, 2018. Please apply early\, as some meetings become oversubscribed (full) before this deadline. If the meeting is oversubscribed\, it will be stated here. Note: Applications for oversubscribed meetings will only be considered by the conference chair if more seats become available due to cancellations. \nDiversity funding: \nFinancial assistance is available for qualified applicants through the GRC Carl Storm Underrepresented Minority Fellowship Program. This program provides a grant to underrepresented minority graduate students\, postdocs\, faculty and scientists to help fund their attendance at their first GRC meeting.  Learn more.
URL:https://ces.b2sg.org/event/grc-22jul18/
LOCATION:Grand Summit Hotel at Sunday River\, 97 Summit Road\, Newry\, ME\, United States
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/GRC.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180722
DTEND;VALUE=DATE:20180824
DTSTAMP:20180722T205207Z
CREATED:20180722T205207Z
LAST-MODIFIED:20180722T205207Z
UID:20437-1532217600-1535068799@ces.b2sg.org
SUMMARY:Postdoctoral Fellow
DESCRIPTION:Postdoctoral fellow positions are available immediately at a leading group in the field of prostate cancer research.  The successful applicant will investigate steroid hormone action\, transcriptional control\, and cell signaling in development and tumorigenesis.  Specifically\, the applicants will develop and use novel and advanced biological approaches\, and genetically-engineered mouse models to uncover gene-expression and genomic and epigenetic alterations in cancer initiating cells in order to understand mechanisms underlying tumor initiation\, progression\, and metastasis. \nWe provide a fruitful research and training environment and competitive salary and fringe benefit.  Applicants should submit their curriculum vitae and the names of three references.  See Zijie Sun lab:  http://www.cityofhope.org/people/sun-zijie. \nMinimum Education and Skills Required for Consideration: \nCandidates should have a recent Ph.D. or M.D/Ph.D. degree in Cancer Biology\, Molecular Biology\, Genetics\, Biochemistry\, Cell Biology\, or a related field. Candidates should be highly self-motivated\, strong working ethic and desire to learn\, and a proven track record of productivity.  Previous experience with mouse models of human diseases\, cancer biology\, and cellular and molecular biology is highly desired.
URL:https://ces.b2sg.org/event/hope-22jul18/
LOCATION:City of Hope\, 1500 East Duarte Road\, Duarte\, 91010\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/02/City-of-hope.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180723
DTEND;VALUE=DATE:20180825
DTSTAMP:20180723T091227Z
CREATED:20180723T091111Z
LAST-MODIFIED:20180723T091227Z
UID:20440-1532304000-1535155199@ces.b2sg.org
SUMMARY:Post Doctoral Associate
DESCRIPTION:A postdoctoral position is available in the laboratory of Dr. Merav Socolovsky in the Department of Cancer Biology at the University of Massachusetts Medical School. We investigate the process of mammalian blood cell differentiation\, with a focus on epigenetics and the cell cycle. Please visit the Socolovsky Lab Website ( http://labs.umassmed.edu/socolovskylab/) for details on available research areas.\n\n\n\n\nQualifications\n\n\n\nApplicants should have a Ph.D. in Cell\, Developmental or Molecular Biology\, be creative and highly motivated.\n\n\n\n\nAdditional Information\n\n\n\n\n\nPlease send a brief statement of your scientific work and interests\, a CV and the name and email address of three references\, to Merav.socolovsky@umassmed.edu\n\n\n\n\n\n(Please do not apply via the UMMS Career Site)
URL:https://ces.b2sg.org/event/umass-22jul18/
LOCATION:UMass Medical School\,  55 N Lake Ave\, Worcester\, MA\, 01655\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/10/umass.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180724
DTEND;VALUE=DATE:20180826
DTSTAMP:20180724T230404Z
CREATED:20180724T230050Z
LAST-MODIFIED:20180724T230404Z
UID:20445-1532390400-1535241599@ces.b2sg.org
SUMMARY:Associate Scientist | Epigenetics
DESCRIPTION:We are seeking a highly motivated\, positive and engaged team player to join our Epigenetic Discovery group. The successful candidate will work on drug discovery projects focused on Epigenetic and Transcriptional targets. Specifically\, the candidate will be expected to design\, develop and execute experiments that include new target validation\, identification of biomarkers\, elucidation of mechanism of action\, executing existing cell based assays\, and evaluating regular lists of chemical matter to support ongoing SAR efforts. Experience with chromatin IP (ChIP) is highly desired. In addition\, the candidate will assist in creating stable cell lines\, and developing and optimizing new cell based assays to support drug discovery efforts. \nResponsibilities will include\, but are not limited to\, the following \n\nIndependently design\, plan and execute scientific experiments\nAnalyze and interpret scientific data\, troubleshoot and suggest new directions\nConduct routine assays to confirm hits from primary screens and support ongoing SAR efforts\nDevelop\, trouble shoot and optimize new cell based biomarker and functional assays\nAccurately maintain written reports and organize data\nPresent projects in team\, department and project review meetings\nIndependently review current literature pertaining to oncology\, epigenetics\, transcriptional regulation and related assays\n\nExperience/Skills/Knowledge Required \n\nMaster’s degree in a scientific discipline with at least 6 years work experience\, or Bachelor’s degree with at least 8 years work experience.\nIn-depth knowledge of cancer biology and epigenetics\nFamiliarity with drug discovery process for epigenetic and transcriptional targets in oncology\nExperience with target ID / validation efforts\nExperience in executing and developing cell-based assays\, and small molecule hit confirmation efforts\nExperience in molecular and cell biology techniques including cell culture\, transfection and transduction techniques (overexpression\, RNAi\, CRISPR)\, stable cell line generation/validation\, viability assays\, functional/phenotypic assays such as viability and apoptosis in 2D and 3D settings\, real time PCR\, protein assays such as immunoblotting and/or protein simple\, RNA assays including qPCR and/or Nanostring\, microscopy. Experience in ChIP assays is desired\nHighly motivated\, positive\, capable of multitasking\, attention to detail\, and innovative\nExcellent time management and organizational skills\, strong written and oral communication skills\, ability to think creatively and solve problems are essential
URL:https://ces.b2sg.org/event/celgene-24jul18/
LOCATION:Celgene San Francisco\, 1500 Owens St\, CA\, 94158\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/08/celgene-1-e1503843775806.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180727
DTEND;VALUE=DATE:20180908
DTSTAMP:20180727T182932Z
CREATED:20180727T182932Z
LAST-MODIFIED:20180727T182932Z
UID:20450-1532649600-1536364799@ces.b2sg.org
SUMMARY:Postdoc Research Associate
DESCRIPTION:Postdoc Research Associate to perform work in the lab doing molecular biology experiments as well as our novel genetically engineered mouse models of kidney cancer. Basic cell and molecular biology techniques will be used such as mammalian cell culture\, transfection\, anchorage-independent growth assays. \n\n\n\n\nMinimum Qualifications: \nPh.D.Ph.D. biomedical sciences or related.
URL:https://ces.b2sg.org/event/unc-27jul18/
LOCATION:University of North Carolina – UNC-Chapel Hill\, Chapel Hill\, NC\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/07/unc-chapel-hill-north-caro-nc.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180803
DTEND;VALUE=DATE:20180905
DTSTAMP:20180803T215247Z
CREATED:20180803T215247Z
LAST-MODIFIED:20180803T215247Z
UID:20453-1533254400-1536105599@ces.b2sg.org
SUMMARY:Postdoctoral Fellow | Cancer Biology
DESCRIPTION:A Postdoctoral Fellow position is available at the Department of Cancer Biology\, Beckman Research Institute at City of Hope. We are looking for a highly motivated postdoctoral fellow interested in studying aging and cancer. Our lab is interested in studying genetic and epigenetic alterations during aging of normal hematopoietic stem cells and in leukemia stem cells that lead to genomic instability\, leukemia development and drug resistance. The lab utilizes bone marrow transplantation and genetic knockout mouse models\, stem cell biology\, and molecular and imaging techniques to study hematopoietic/leukemic stem cells\, and molecular regulation of genomic instability. The outstanding candidate\, particularly with minority background\, may also be eligible for NIH T32 postdoctoral training fellowship in the DNA-damage-response-and-oncogenic-signaling program.  \nThe ideal candidate is expected to have extensive experience in molecular biology and cell biology. Experience with hematology and rodent models preferred. The candidate should be self-motivated\, with a proven track record of productivity. To apply\, please send a cover letter stating your research interests and experience along with a curriculum vitae and the names of three references to Dr. WenYong Chen: wechen@coh.org.  \nEducation and Skills Required for Consideration:\nPhD in Molecular Biology\, Biochemistry\, Stem Cell Biology or related fields.  \nStrong interest in aging and cancer biology.  \nExtensive experience with basic molecular and cell biology skills.  \nExperience in hematology and handling animal models preferred.  \nExperience with epigenetic techniques preferred.  \nExperience with tissue collection\, histology and immunohistochemistry.  \nExperience with cell culture\, immunofluorescence\, flow cytometry\, and cell-sorting.  \nStrong work ethic.  \nGood problem solving skills and passion to follow relevant literature.  \nAbility to conduct independent research.  \nExcellent written and verbal communication skills. Evidence of productivity reflected in first author publications in peer-reviewed journals. 
URL:https://ces.b2sg.org/event/hope-3aug18/
LOCATION:City of Hope\, 1500 East Duarte Road\, Duarte\, 91010\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/02/City-of-hope.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180805
DTEND;VALUE=DATE:20180907
DTSTAMP:20180805T061116Z
CREATED:20180805T061116Z
LAST-MODIFIED:20180805T061116Z
UID:20455-1533427200-1536278399@ces.b2sg.org
SUMMARY:Postdoctoral Fellow
DESCRIPTION:The Van Andel Research Institute has a position available for one Postdoctoral Fellow under the direction of Peter W. Laird\, Ph.D. \nThe Laird Laboratory focuses on the role of epigenetics in cancer\, combining mechanistic studies in model systems\, analysis of human cancer tissues\, advanced technology development\, and epigenomic data analysis. \nA major focus of this position will be to investigate cellular epigenetic heterogeneity as a predeterminant of malignant transformation potential using single cell epigenomics in mouse models. \nThis postdoctoral position is available immediately for a motivated PhD graduate who meets the qualifications and description outlined below. \nQualifications: \n\nA Ph.D. graduate with experience and publications in the fields of molecular biology\, cancer genomics\, and/or mouse genetics.\nAn ideal candidate will have experience with various molecular biology techniques (i.e. DNA/RNA work\, PCR\, qPCR\, Western blot)\, cell culture and/or mouse models.\nMust provide the names of three individuals who can provide recommendations and present a scientific seminar describing his or her previous research.\n\n\nDescription of a Successful Candidate: \n\nA “team” focused scientist\nA self-motivated and driven individual who is able to exhibit exceptional research productivity and take responsibility for independent management of the project\nA detail-oriented researcher who thinks critically to effectively design experiments and solve complex research problems\nA strong ability to take initiative and work independently\nA collaborative\, hands-on researcher who proactively shares knowledge and expertise with lab members and has an interest in helping junior lab members\nExcellent written and oral communication skills\n\n\nJob Functions: Van Andel Research Institute (VARI) provides postdoctoral training opportunities to scientists beginning their research careers. The fellowships are to help promising scientists advance their knowledge and research experience and at the same time support the research endeavors of VARI under the mentorship of a VARI Faculty member. \nWhile this project is currently funded\, an integral part of postdoctoral training is the process of preparing a research proposal and writing a fellowship application. All VARI Postdoctoral Fellows are encouraged to apply for external funding as soon as it is practical and reasonable after hire. Receiving a fellowship award provides recognition for both the fellow and VARI!
URL:https://ces.b2sg.org/event/va-4aug18/
LOCATION:Van Adel Research Institute\, Grand Rapids\, MI\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/12/van-andel-research-inst-vari-vanandel.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180808
DTEND;VALUE=DATE:20180910
DTSTAMP:20180808T074415Z
CREATED:20180808T074415Z
LAST-MODIFIED:20180808T074415Z
UID:20457-1533686400-1536537599@ces.b2sg.org
SUMMARY:Bioinformatics Analyst
DESCRIPTION:The Van Andel Research Institute has a position available for one Bioinformatics Analyst under the shared direction of Peter W. Laird\, Ph.D and/or Hui Shen\, Ph.D. Depending on the interests and expertise of the successful candidate\, the position can be a sole appointment in either the Laird or Shen laboratory\, or a joint appointment between the two labs. \nThe Laird Laboratory focuses on the role of epigenetics in cancer\, combining mechanistic studies in model systems\, analysis of human cancer tissues\, advanced technology development\, and epigenomic data analysis. \nThe Shen Laboratory focuses on the epigenome and its interaction with the genome in various diseases\, with a specific emphasis on female cancers and cross-cancer comparisons relying on innovative computational tool development and epigenomic data analysis. \nAs a Bioinformatics Analyst on our team\, your first and foremost responsibility will be to work closely with lab members on the analysis of next-generation sequencing data. Additional responsibilities might include: \n\nMaintain and support bioinformatics software.\nAssist research faculty in data mining of publicly available data sets.\nAnalyze data through established workflows and pipelines.\nEngage in bioinformatics literature to ensure the availability of robust methods\, resources\, and data sources to support core users.\nMaking figures for manuscripts\nDirect and guide DNA\, RNA and protein sequence database searches and the computational analysis of resulting data.\nMaintain computational infrastructure and control the flow of samples and information for large-scale studies.\nRecognize and report problems with the data management process and fix problems whenever possible.\n\n\nThis position is available immediately for a motivated scientist who meets the qualifications and description outlined below. \nQualifications: \n\nBachelor’s degree in bioinformatics\, computational and systems biology\, mathematical\, physical\, or computer science with a Master of Science (MS) preferred. 2+ years of experience in computer programming and computational biological applications.\nExperience in such functional areas as image analysis\, NGS data analysis\, and data integration. Understanding of cellular and molecular biology and/or genetics is a plus.\n1-3 years of experience in a scripting language (Python\, Perl\, etc.). A working knowledge of R is expected. Working knowledge of public biological databases (NCBI\, ENCODE\, ENSEMBL\, UCSC\, etc.).\nContributions to the broader bioinformatics community through software and methods development.\nMust provide the names of three individuals who can provide recommendations and present a scientific seminar describing his or her previous research.\n\n\nDescription of a Successful Candidate: \n\nA “team” focused scientist\nA self-motivated and driven individual who is able to exhibit exceptional research productivity and take responsibility for independent management of the project\nA detail-oriented researcher who thinks critically to effectively design experiments and solve complex research problems\nA strong ability to take initiative and work independently\nA collaborative\, hands-on researcher who proactively shares knowledge and expertise with lab members and has an interest in helping junior lab members\nExcellent written and oral communication skills\n\n\nHOW TO APPLY \nIf you possess these attributes and enjoy working with motivated and driven people\, we would welcome speaking with you and encourage you to apply today! \n\nA cover letter describing your research interests\, experience\, and how you might contribute to Laird Lab Research.\nAn up-to-date Curriculum Vitae.\nA list of 3 individuals who have agreed to act as references along with their contact details.\n\nPlease contact Eric Miller (eric.miller@vai.org) for further information or questions\, or if you have any difficulty with the application process.
URL:https://ces.b2sg.org/event/vari-7aug18/
LOCATION:Van Adel Research Institute\, Grand Rapids\, MI\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/12/van-andel-research-inst-vari-vanandel.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180810
DTEND;VALUE=DATE:20180912
DTSTAMP:20180810T205107Z
CREATED:20180810T204703Z
LAST-MODIFIED:20180810T205107Z
UID:20459-1533859200-1536710399@ces.b2sg.org
SUMMARY:Senior Scientific Researcher
DESCRIPTION:We are seeking a Senior Scientific Researcher in the Department of Molecular Biology to support the production and optimization of genetically-modified cellular models. This position will be within the newly-established Cell Engineering Lab\, wherein she/he will facilitate the design\, execution\, and validation of cell line engineering projects initiated by researchers across Genentech — with the ultimate goal of generating more effective in vitro/ex vivo disease models and novel contexts for functional genomic screening. The candidate is expected to work creatively and independently within an extremely dynamic\, collaborative research environment. \nA self-motivated candidate with a PhD in Genetics\, Molecular Biology\, Biochemistry\, Cancer Biology\, or a related discipline. Qualified candidates will have a skillset demonstrating successful\, documented application of molecular genetics/genome engineering either in cell-based systems or model organisms. Preferred expertise includes some or all of the following: DNA nucleases\, 2D and 3D cell culture\, RNA interference (siRNA/shRNA)\, reporter gene assays\, primary and/or stem cell models\, molecular cloning\, RNA/DNA/protein quantification\, epigenetics\, and viral vector development/use. Working knowledge of pooled vector-based screening\, Next-Gen Sequencing (NGS)\, biostatistics\, and/or basic bioinformatics is desirable. The successful candidate will be team-oriented\, highly organized\, and have excellent communication skills\, both written and verbal.
URL:https://ces.b2sg.org/event/genentech-10aug17/
LOCATION:Genentech\, 1 DNA Way\, South San Francisco\, CA\, 94080\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/genentech-logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180811
DTEND;VALUE=DATE:20180913
DTSTAMP:20180811T162945Z
CREATED:20180811T162945Z
LAST-MODIFIED:20180811T162945Z
UID:20461-1533945600-1536796799@ces.b2sg.org
SUMMARY:Postdoctoral Positions in Translational Leukemia Research
DESCRIPTION:The Translational Leukemia Research Program at the Perlmutter Cancer Center and New York University (NYU) School of Medicine invites post-doctoral applications in the laboratory of Dr. Raoul Tibes\, the Director of Leukemia Program. The focus of the Laboratory is the molecular-genomic characterization of primary acute myeloid leukemia (AML)\, myelodysplastic syndrome (MDS) and myeloproliferative neoplasm (MPNs) in correlation of their response to current therapies and novel investigational agents\, and understanding the mechanisms of drug resistance. The Tibes laboratory has been instrumental in providing pre-clinical data based on functional genomic information for several novel treatments (i.e. epigenetic and apoptosis targeting combinations) that are currently in clinical trials for AML\, MDS and MPNs. The Tibes laboratory is highly collaborative and the successful candidate will work with leading academic clinicians and basic scientists at NYU\, other academic Cancer Centers\, and pharmaceutical companies to discover and delineate the clinical path for novel therapeutic agents. The laboratory publishes in high-impact journals and former members of the laboratory hold positions at academic institutions or biotech and pharmaceutical companies. \nCurrently available projects include: understanding the mechanisms of the anti-leukemic activity DNA damage repair interference by WEE1 and CHEK1 inhibition; characterizing epigenetic/hypomethylating agent resistance and the design of rational hypomethylating agent based combinations in AML and MDS; as well as novel therapeutic approaches for MPNs. \nThe successful candidate will have strong dedication and independence\, effectively communicate their work by publishing the results in premier journals and will be involved in grant writing with an opportunity to submit their own career awards. The applicant and projects will benefit from a scientifically stimulating environment\, with extensive resources and opportunities to collaborate within NYU and externally. There is close interaction with the PI and candidates will be actively involved in various aspects of translational cancer research and drug development. The Lab is funded by several agencies including the NCI\, LLS and ASCO and at the institutional level. \nIn addition to world-class research facilities and to opportunities within the Lab and Cancer Center\, NYU Langone Health and NYU School of Medicine has a robust career development program led by our Office of Postdoctoral Affairs. One of only 17 schools to receive an NIH BEST (Broadening Experiences in Scientific Training)\, the Office of Postdoctoral Affairs offers over 30 courses and workshops on career planning\, communication skills\, negotiating\, and conflict management\, as well as career-specific training for careers in academia\, pharma/biotech\, science policy\, medical communications\, and many more. Additional information can be found at www.med.nyu.edu/postdoc \nRequirements: Applicants should have a Ph.D. degree (or equivalent) in molecular biology\, cancer biology\, or relevant fields. Applicant must be able to work independently in a fast-paced\, dynamic research environment. \nApplication process: Interested applicants should send a letter of motivation\, a curriculum vitae\, and the contact information of 3 references as a single combined pdf file (subject line post-doctoral application) to raoul.tibes@nyumc.org.
URL:https://ces.b2sg.org/event/nyu-11aug18/
LOCATION:NYU School of Medicine\, 550 1st Avenue\, New York\, NY\, 10016\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/04/2a2e114fdf83fccb05f96397bc705362-rimg-w720-h415-gmir-e1524048116774.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180812
DTEND;VALUE=DATE:20180929
DTSTAMP:20180812T160400Z
CREATED:20180812T160400Z
LAST-MODIFIED:20180812T160400Z
UID:20463-1534032000-1538179199@ces.b2sg.org
SUMMARY:Faculty Position in Cancer Biology/Genetics
DESCRIPTION:The Life Sciences Institute (LSI) at the University of Michigan invites applications for an open rank faculty position in Cancer Biology/Genetics. Successful candidates will have experience in cancer biology/genetics\, with specific research targets related to cancer metabolism\, cancer genetics/genomics/epigenetics\, chemical biology\, tumor microenvironment\, or tumor immunology. \nFaculty will hold both a Research Professor appointment in the LSI as well as an Assistant\, Associate\, or Full Professor appointment in one of the University’s schools and colleges. Joint appointments are likely in the Medical School\, the College of Literature\, Science\, and the Arts\, the College of Engineering\, the School of Public Health\, the Dental School\, or the College of Pharmacy. All faculty are expected to participate in the University of Michigan’s teaching mission and to demonstrate commitment to service in the larger community. Candidates are expected to develop an internationally recognized program of scholarly research and to excel in teaching and mentoring at the graduate level. \nThe LSI is a scientific enterprise at the University of Michigan dedicated to fundamental discovery in the biological sciences in a state-of-the-art collaborative physical space (www.lsi.umich.edu). Through basic discovery\, the institute seeks to advance knowledge in critical areas of biology with an ultimate goal of contributing to human health including cancer\, metabolic disorders\, brain disorders\, and infectious disease. \nThe LSI is currently home to 22 faculty members in the disciplines of chemistry\, cell biology\, physiology\, genetics\, chemical biology\, biophysics\, structural biology\, and stem cell biology\, including three Howard Hughes Medical Institute investigators and eight members of the National Academies of Medicine or Sciences. Our culture centers on upholding scientific excellence\, embracing risk\, and collaborating across disciplines to achieve an impact greater than the sum of our individual parts. \nIn addition to faculty labs\, the institute houses state-of-the-art instrumentation and computing\, including the following transmission electron microscopes: 300kV Titan Krios\, 200kV Talos Artica\, 120kV Tecnai G2 Spirit\, and 100vK Morgagni. Additional institute resources include high-throughput screening center with extensive chemical collections and a unique library of natural product extracts\, and a comprehensive protein production and X-ray crystallography facility. The LSI is also home to the U-M Program in Chemical Biology. \nApplication materials are due on Friday\, September 28\, 2018. Interested applicants will submit a cover letter\, curriculum vitae\, a summary of future research plans (up to 4 pages)\, contact information for three faculty who will write a letter of recommendation\, and copies of up to three publications on our online application site (lsi.science/2018facultyposting). Individuals from groups historically under-represented in the sciences are strongly encouraged to apply.
URL:https://ces.b2sg.org/event/mi-12aug18/
LOCATION:University of Michigan\, 500 S State St\, Ann Arbor\, MI\, 48109\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/uni-michigan.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180813
DTEND;VALUE=DATE:20180915
DTSTAMP:20180813T120800Z
CREATED:20180813T120800Z
LAST-MODIFIED:20180813T120800Z
UID:20465-1534118400-1536969599@ces.b2sg.org
SUMMARY:Program Co-Leader - Cancer Molecular Genetics
DESCRIPTION:The Program Co-Leader\, Cancer Molecular Genetics is responsible for the oversight\, development\, implementation and evaluation of the cancer molecular genetics related programs and initiatives at Massey Cancer Center. \n\n\n\n\nPosition Responsibilities\n\nThe Virginia Commonwealth University (VCU) School of Medicine and Massey Cancer Center are seeking a successful scientist and leader to serve as the Program Co-Leader of the Cancer Molecular Genetics (CMG) research program at the cancer center. The CMG program consists of a multidisciplinary group of 26 investigators from 12 academic departments representing four schools. This tenure-eligible faculty position will be a key member of Massey’s leadership team. \nResponsibilities \n\nProvide oversight\, development\, implementation and evaluation of cancer molecular genetics related programs and initiatives at Massey Cancer Center\nPartner with the Director\, Associate Directors and other Program Leaders at Massey to enhance the cancer center’s scientific goals and objectives\nWork closely with leadership to encourage and facilitate multidisciplinary collaboration and translational research at the cancer center\nConduct fundamental research that can be translated into improved approaches for diagnosis\, prevention\, and treatment of neoplastic diseases\n\n\nResearch can include but not limited to the following areas: \n\nEpigenetic mechanisms in cancer development and progression: Understanding the regulation and interaction of histone modifications and other epigenetic controls including DNA methylation and miRNA; recognition of these post-translational modifications in DNA-chromatin complexes by nucleosome remodeling factors\, and the role of miRNA in these processes\nDefinition of the functional significance of genes involved in cancer development and progression\, and exploiting this information to identify and validate promising targets\nDefinition of the pathways that delete and silence tumor suppressor genes in human cancers\n\n\n\n\n\n\nRequired Qualifications\n\n\nPhD or MD/PhD\nArea of cancer research expertise in epigenetics or epigenomics\nSolid track record of scientific achievement reflected by both sustained and recent impactful publications and extramural peer-reviewed research funding in cancer related research as a Principal Investigator\n\n\n\n\n\nPreferred Qualifications\n\n\nProven leadership\, relationship building\, and strong communication skills\nExperience working in a matrix environment within academic medicine\nProven success in collaborating with multi-disciplinary teams\nDemonstrated experience working with and fostering diverse faculty\, staff\, and student environment or commitment to do so as a faculty member at VCU
URL:https://ces.b2sg.org/event/vcu-13aug18/
LOCATION:Virginia Commonwealth University\, 907 Floyd Ave\, Richmond\, VA\, 23284\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/09/VCU-virginia-commonwealth-e1506279590219.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180815
DTEND;VALUE=DATE:20180917
DTSTAMP:20180815T112224Z
CREATED:20180815T112224Z
LAST-MODIFIED:20180815T112224Z
UID:20469-1534291200-1537142399@ces.b2sg.org
SUMMARY:Research Scientist - Leukemia
DESCRIPTION:Dr. Kapil N. Bhalla is currently seeking a Senior Research Scientist who will be responsible for conducting research in his NIH-funded laboratory. The focus of the basic and translational research in this laboratory includes the biology and developmental therapeutics related to epigenetic mechanisms involving histone deacetylases\, methyltransferases and demethylases\, BET proteins\, as well as the chaperone biology of heat shock proteins and their cancer relevant client proteins regulating cell growth\, differentiation and survival of the human leukemia stem/progenitor cells. The qualified candidate must possess a Ph.D. in Biology\, Biological Sciences\, Life Sciences or related field and a keen interest and experience in cancer research. The candidate must have completed at least a 3 year Post-doctoral fellowship in an area relevant to the focus of research in Dr. Bhalla’s laboratory. The qualified candidate must have the ability to troubleshoot in the design and conduct of the laboratory studies. Experience in molecular studies involving gene transfection\, analysis of gene expression through QPCR\, microarrays\, immunoblots and flow cytometry\, as well as experience in chromatin immunoprecipitation studies\, evaluation of protein biochemistry with 2D gels and the yeast-two-hybrid system\, and tissue culture techniques is required. Experience in the ability to utilize CRISPR technology for gene editing and to utilize confocal microscopy for molecular imaging is highly desired. Experience in xenograft and genetically-engineered animal models of cancer and/or leukemia\, and confocal microscopy is also desired. An outstanding research environment\, new laboratory and core facilities are provided.  \nThe salary range is: min-$53\,200\, mid-$66\,500 and max-$79\,800.  \nKEY FUNCTIONS  \nResearch Design and implementation  \nPlans\, organizes\, coordinates\, directs and conducts scientific research projects. Develops and maintains standard procedures and protocols to ensure the quality and integrity of the procedures performed. Coordinates with other investigators to provide appropriate support on analytical techniques. Maintains detailed experimental records\, evaluates resulting research data\, and presents findings to physicians and/or professional groups.  \nData Analysis  \nAnalyzes and evaluates research data and revises techniques and approaches to work problems. Works with the Principal Investigator on projects in the area of biomarker development and leukemia biology. Participates in adopting new techniques and learning new skills to enhance research efforts.  \nLab Development/Publications  \nSupervises\, mentors\, and counsels trainees and other laboratory personnel with respect to proper laboratory techniques\, the use of laboratory equipment and safety procedures. Publications/Manuscripts and Presentations. Contributes to manuscripts and prepares documents for publication. Compiles\, writes\, and submits reports to superior. Presents results at national meetings.  \nOther duties as assigned.  \nEDUCATION  \nRequired: PhD in one of the natural sciences or related field or Medical degree.  \nEXPERIENCE  \nRequired: With PhD\, no experience required. With Medical degree\, two years of experience in experimental or scientific work. 
URL:https://ces.b2sg.org/event/mda-15aug18/
LOCATION:MD Anderson Cancer Center\, 1515 Holcombe Blvd\, Houston\, TX\, 77030\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/MDAnderson.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180816
DTEND;VALUE=DATE:20180918
DTSTAMP:20180816T170340Z
CREATED:20180816T170340Z
LAST-MODIFIED:20180816T170340Z
UID:20471-1534377600-1537228799@ces.b2sg.org
SUMMARY:Research Scientist
DESCRIPTION:Job description:  \nConduct grant supported research into the mechanisms of action of natural products in inhibiting colon cancer through modulation of inflammation. Responsible for designing and performing experiments\, analyzing data\, and contributing to publication of results. This position is needed in order for important research to be completed and data compiled on a particular project that ends 2-28-19. If additional funding is not received by the faculty member to continue to support a Research Scientist after the project funds are exhausted\, the position will be eliminated. \n  \nPreferred Qualifications: \nWorking knowledge of QPCR\, WESTERNS ASSAYS\, CYTOKINE AND CHEMOKINE ELISAS\, IMMUNOHISOCHEMISTY AND WORKING WITH RESEARCH ANIMALS.
URL:https://ces.b2sg.org/event/uth-16aug18/
LOCATION:UT Health Science Center in San Antonio\, 7703 Floyd Curl Drive\, San Antonio\, TX\, 78229\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/01/ut-health-science-center-san-antonio-e1514899885167.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180817
DTEND;VALUE=DATE:20180919
DTSTAMP:20180818T020740Z
CREATED:20180818T020740Z
LAST-MODIFIED:20180818T020740Z
UID:20473-1534464000-1537315199@ces.b2sg.org
SUMMARY:Faculty Position – Brain Tumor Research
DESCRIPTION:The Division of Brain Tumor Research within the Department of Developmental Neurobiology at St. Jude Children’s Research Hospital (St. Jude) is recruiting for a JUNIOR FACULTY member. We seek an exceptional and creative scientist to lead an innovative laboratory-based research program using cutting-edge approaches to elucidate mechanisms relevant to neural development and tumorigenesis. Areas of interest include mechanisms of neural cell fate specification and differentiation\, connections between epigenetic regulation\, neural development and cancer\, signaling pathways driving disease pathogenesis in pediatric brain tumors\, and developmental and cellular origins of brain tumors. Early career investigators interested in contributing to a culture of excellence at St. Jude are particularly encouraged to apply. This search is also open for mid-career investigators with a strong record of independent research. \nThe research environment at St. Jude is highly interactive with collaborative opportunities across all basic research and clinical departments\, and access to state-of-the-art institutional shared resources managed by Ph.D. level scientists. Division of Brain Tumor Research investigators have access to specialized departmental shared resources that include an integrated support structure for preclinical modeling including genetically engineered and patient-derived xenograft mouse models\, human stem cells\, cell sorting\, live cell imaging\, and advanced image processing and analysis. The Division of Brain Tumor Research investigators are also members of the Neurobiology and Brain Tumor Program within the St Jude Comprehensive Cancer Center\, and there are abundant opportunities for collaborative interactions with world-class clinical investigators.
URL:https://ces.b2sg.org/event/stjude-17aug18/
LOCATION:St. Jude Children’s Hospital\, 262 Danny Thomas Pl\, Memphis\, TN\, 38105\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/stjude.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180819
DTEND;VALUE=DATE:20180921
DTSTAMP:20180819T180332Z
CREATED:20180819T180332Z
LAST-MODIFIED:20180819T180332Z
UID:20481-1534636800-1537487999@ces.b2sg.org
SUMMARY:Senior Scientist III
DESCRIPTION:The Translational Oncology and Precision medicine group at Abbvie uses advanced methods to discover biomarkers and implement translational medicine strategies to progress Abbvie’s innovative Oncology pipeline. We are currently seeking a highly motivated individual to join our team as a Senior Scientist III to lead and oversee development and execution of Translational medicine strategy\, including companion diagnostic (CDx) development for Abbvie sponsored clinical trials. As a member of both research and clinical development project teams he/she will have the opportunity to work in a highly collaborative environment to support projects across all phases of clinical development.\nThe key responsibilities will be:\n\n\nLead development and implementation of translational medicine strategies for Oncology compounds\nApply multiple genomic and biochemical technology platforms to demonstrate target engagement\, develop and implement patient selection and diagnostic strategies.\nPartner with clinical and discovery groups to create high quality biomarker strategies in the clinic\nImplement potential novel bioanalytical platforms and introduce new ways to incorporate biomarkers into clinical program designs.\nDesign and perform experiments to elucidate resistance mechanisms that can be developed into biomarkers and new therapeutics.\nAuthor the translational research and CDx portions in key clinical documents including protocol/informed consent\, Clinical study Report\, Investigators Brochure\, etc. Contribute the scientific and technical sections as it relates to translational science and CDx in key regulatory documents including INDs\, FDA briefing books\, and submission documents (including NDAs\, IDEs & PMAs).\nProvide hands-on clinical trial support\, including sample management\, lab work\, and report generation.\nFunction as an internal expert in oncology biomarkers and precision medicine and actively educate other team members through knowledge sharing.\nPresent and report data in external meetings and publications.\n\n\n\nLevel commensurate with experience.\n\n\n\nB.S\, M.S. and/or Ph.D. in Cancer Biology\, Cell Biology\, Molecular Biology or related field with 6-8+ (Ph.D)\, 12-14+ (M.S)\, or 14-16+ (B.S) years of experience in developing and implementing translational medicine strategies\, and a track record of success in the pharma industry.\nStrong scientific background in tumor biology and expertise in immuno-oncology\, epigenetics\, or tumor immune microenvironment is preferred.\nDemonstrated technical excellence and expertise in Translational medicine; including hands-on experience taking small molecules and/or biologics through preclinical to clinical development.\nCompanion diagnostics development experience is a plus\nExperience in analysis of large datasets and knowledge of biostatistics\nExperience in the development and utilization of biomarkers\, various technologies/platforms ( –omics technologies\, immunohistochemistry and immunoassays\, etc.).\nEffectively work in a cross-functional team environment\, interacting with various levels within the organization as well as vendors/academic sites/KOLs\nOrganization\, orientation to details\, and effective time management with an ability to adapt to changing priorities\nExcellent interpersonal and communication skills.\nMust be able to work effectively on multiple oncology programs in a fast dynamic environment.\n\n\n\nKey AbbVie Competencies:\n\n\nBuilds strong relationships with peers and cross functionally with partners outside of team to enable higher performance.\nLearns fast\, grasps the “essence” and can change course quickly where indicated.\nRaises the bar and is never satisfied with the status quo.\nCreates a learning environment\, open to suggestions and experimentation for improvement.\nEmbraces the ideas of others\, nurtures innovation and manages innovation to reality.
URL:https://ces.b2sg.org/event/abbvie-19aug18/
LOCATION:AbbVie – Lake County\, IL\, Lake County\, IL\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/11/abbvie-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180819
DTEND;VALUE=DATE:20180921
DTSTAMP:20180820T003152Z
CREATED:20180820T003152Z
LAST-MODIFIED:20180820T003152Z
UID:20498-1534636800-1537487999@ces.b2sg.org
SUMMARY:Vice Chair of Research - Gastrointestinal Oncology
DESCRIPTION:The H. Lee Moffitt Cancer Center and Research Institute (Moffitt) is seeking an outstanding investigator who is a leader in the Gastrointestinal (GI) cancer research field\, and who will serve as Vice Chair of Research of the Gastrointestinal Oncology Department of Moffitt. The expertise of the Applicant should be evident in top-tier publications\, extramural funding\, an established stature in the GI cancer research field\, and a creative portfolio of research programs that will complement ongoing high-profile research conducted by Cancer Center members in the areas of tumor immunity\, epidemiology\, molecular oncology\, cancer metabolism\, imaging\, genetic and epigenetic control\, tumor biology\, mathematical oncology and evolution\, and cancer drug discovery and development.\n\nCandidates must hold a PhD degree\, qualify for faculty appointment as a tenure-track Senior Member/Professor or as an Associate Member/Associate Professor\, and have demonstrated skills in leadership and administrative roles. The generous recruitment package includes a highly competitive salary\, a large laboratory start-up fund\, ample laboratory space and a stimulating and highly collaborative and collegial environment.\n\nQualified applicants should send a cover letter\, their Curriculum Vitae\, a synopsis of their past and current research programs\, and their vision for developing collaborative translational GI Research Programs\, to Dr. John L. Cleveland\, Associate Center Director of Basic Science at Moffitt\, via e-mail to Yvette.Mieles@moffitt.org.
URL:https://ces.b2sg.org/event/mof-19aug18/
LOCATION:Moffitt Cancer Center Magnolia Campus\, 12902 USF Magnolia Drive\, Tampa\, FL\, 33612\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/Moffitt-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180820
DTEND;VALUE=DATE:20180901
DTSTAMP:20180820T134610Z
CREATED:20180820T134610Z
LAST-MODIFIED:20180820T134610Z
UID:20503-1534723200-1535759999@ces.b2sg.org
SUMMARY:Research Specialist
DESCRIPTION:The purpose of this position is to design and carry out research projects on fundamentals of chromatin regulation and RNA fate during normal development and in carcinogenesis\, as well as on translating the findings of fundamental biology for clinical applications in oncology using in vitro assays as well as human cells\, mouse\, and Drosophila model organisms; support laboratory staff by maintaining laboratory supplies and equipment; maintaining logs. \nDesign/carry out experiments and collect/analyze data \n\nApply biochemical and molecular biology techniques (molecular cloning\, Western blot\, qRT-PCR\, ChIP\, ChIP-seq\, protein purification\, protein complexes reconstruction in vitro) and microscopy to conduct the research on epigenetic regulation of development and cancer.\nAssist with setting up experiments for other lab members.\nTroubleshoot experiments; resolve problems by examining and evaluating data and selecting corrective steps.\n\n\nMaintain cell cultures and Drosophila collections \n\nInventory and maintain cell cultures and Drosophila stocks.\n\n\nManage Epigenetics Laboratory \n\nPerform preventative maintenance on equipment\nTroubleshoot equipment breakdowns\nCall for repairs\nMaintain daily logs on experimental procedures\, protocols\, and equipment\nMaintain supply inventory\nMaintain lab cleanliness\, clean equipment after experiments\nProvide indirect supervision of lab staff\nAssist with article preparation\nParticipate in educational opportunities to stay current in field\n\n\nRequired Competencies: \n\nStrong communication skills.\nDetail oriented.\nWell organized.\nKnowledge of fundamental biology and bioinformatics.\nAbility to work with minimal supervision.\nAbility to follow written protocols.\n\n\n_______________________________________________________________________________________ \nMinimum Requirements: \n\nBachelor’s degree in natural sciences\, biology\, biological anthropology\, or chemistry.\n5 years experience working in a Drosophila research lab.\nExperience producing and analyzing high-throughput sequence data using Drosophila as a model organism.\nHistory of publications in peer-reviewed journals-must provide evidence.\nExperience with confocal microscopy\, biostatistics\, bioinformatics\, and qPCR.\nSuccessful completion of criminal history background check.\n\n\nIn compliance with federal law\, all persons hired will be required to verify identity and eligibility to work in the US and to complete the required employment eligibility verification form upon hire. \nPreferred Qualifications: \n\nExperience with RNA Fluorescence in Situ Hybridization.\nExperience in manuscript preparation.\nExperience with live-cell imaging.\nLab management experience.
URL:https://ces.b2sg.org/event/und-20aug18/
LOCATION:University of North Dakota\, Grand Forks\, ND\, 58203\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/06/University-of-North-Dakota-e1498071509283.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180821
DTEND;VALUE=DATE:20180923
DTSTAMP:20180821T114631Z
CREATED:20180821T114631Z
LAST-MODIFIED:20180821T114631Z
UID:20508-1534809600-1537660799@ces.b2sg.org
SUMMARY:Senior Scientist - Discovery Oncology
DESCRIPTION:We are seeking a highly qualified scientist with a strong background in oncology to join our Discovery Oncology team in Boston. The successful candidate will have a track record of innovative and collaborative research\, demonstrated through peer-reviewed publications. Primary responsibilities will include designing and carrying out experiments in the lab to build and support projects in the early discovery pipeline. An ability to communicate clearly and collaborate effectively with colleagues in the discovery group as well as scientists from different disciplines will be essential.\nThe specific responsibilities of the candidate include but are not limited to:\n\n\nDesign\, conduct\, interpret and report in vitro and cellular oncology studies using a wide range of established methodologies.\nDevelop new methods and protocols where needed.\nEnsure data generated is communicated in a concise\, easy to understand manner to the appropriate teams and stakeholders.\nMonitor\, review and critically interpret published work to guide internal research\nContribute scientifically to oncology drug discovery research programs\, including identification and validation of novel targets.\nCollaborate with members from other functional areas\, including medicinal chemistry\, in vivo and in vitro pharmacology and translational sciences.\nWork with external academic\, biotechnology\, and contract research organizations.\n\n\nQualifications \nEducation Minimum Requirement: PhD in an area relevant to oncology\nRequired Experience and Skills:\n\nA minimum of 1 year of post-doctoral experience in oncology.\nDeep technical and practical experience in cellular models and pathways of cancer.\nCandidate should be a strong team player with excellent oral and written communication skills and with a demonstrated ability to work independently to design experiments\, interpret data\, troubleshoot\, and suggest next steps.\n\n\nPreferred Experience and Skills:\n\nKnowledge of epigenetics\, DNA damage repair and/or immuno-oncology.\nProven record of innovative thinking to propose and champion new ideas and solve problems.\nDemonstrated ability to thrive in a team environment.\nPrior drug discovery experience.\n\n\nYour role at Merck is integral to helping the world meet new breakthroughs that affect generations to come\, and we’re counting on your skills and inventiveness to help make meaningful contributions to global medical advancement. At Merck\, we’re inventing for life.\nIf you need assistance and/or a reasonable accommodation due to a disability during the application or the recruiting process\, please send a request to staffingaadar@merck.com.
URL:https://ces.b2sg.org/event/merck-21aug18/
LOCATION:Merck\, 33 Avenue Louis Pasteur\, Boston\, MA\, 02115\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/09/merck.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180822
DTEND;VALUE=DATE:20180924
DTSTAMP:20180822T113546Z
CREATED:20180822T113546Z
LAST-MODIFIED:20180822T113546Z
UID:20525-1534896000-1537747199@ces.b2sg.org
SUMMARY:Senior Scientist - Epigenetics
DESCRIPTION:We are seeking a highly motivated scientist to join our Epigenetics Center of Excellence. The successful candidate will have a strong foundation in transcription regulation in cancer with previous experience in Drug Discovery. The candidate will be expected to design\, plan and execute biological studies for identifying new targets in various therapeutic areas and to support drug discovery projects from target identification to nomination of development candidates. \nSkills/Knowledge Required \n\nPh.D. in Biology or related scientific discipline with at least 6 years of relevant cancer research experience\, preferably in Industry; Master’s degree with at least 12 years work experience; or\, Bachelor’s degree in a scientific discipline with at least 14 years work experience.\nProficient in cell biology including shRNA and CRISPR technologies\nExperience in target validation\, functional and biomarker cell-based assay development.\nExperience in performing and/or interpreting epigenetic profiling studies is highly desired (DNA methylation\, RNA-sequencing\, ChIP-sequencing and ATAC-sequencing).\nSolid experience in Drug Discovery.\nHighly motivated\, innovative and strong team player. Experience to work in a cross-functional team\nExcellent time management and organizational skill.\nStrong communication skills\, both written and oral.\nStrong ability to work in a fast-paced environment is essential.
URL:https://ces.b2sg.org/event/celgene-22aug18/
LOCATION:Celgene San Diego\, 10300 Campus Point Dr\, San Diego\, CA\, 92121\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/08/celgene-1-e1503843775806.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180823
DTEND;VALUE=DATE:20180925
DTSTAMP:20180823T114245Z
CREATED:20180823T113736Z
LAST-MODIFIED:20180823T114245Z
UID:20547-1534982400-1537833599@ces.b2sg.org
SUMMARY:Postdoctoral Research Associate
DESCRIPTION:Department Eppley Inst Research 50000686 Business Unit(College/Institute) Eppley Institute FTE: \n100 \nReg-Temp Full-Time Regular Work Schedule TBD 8-5pm Requisition Category Research – Academic Requisition Title Postdoctoral Research Associate Job Title/Academic Rank Postdoctoral Research Associate Additional Requisition Title Appointment Type A1 – REG OTHER ACAD SAL Salary Range Salary Commensurate with Experience Job/EEO Category Professional Non-Faculty (Includes Other Academic) Job Requisition Begin Date 08/27/2018 \n\n\nPosition Qualification \n\n\nPosition Summary\n\nResearch projects that will involve studies in B-cell malignancies including disease biology\, tumor microenvironment interactions and immune profile as well as pre-clinical evaluation of anti-cancer therapeutics \n\n\n\nRequired Qualifications\n\nCandidates should have PhD in cancer biology\, immunology or related field. Basic and molecular biology techniques required. Experience with mouse studies and cancer immunology is preferred. The candidates should be highly motivated with good oral and written communication skills in English. \n\n\n\nSupplemental Qualifications\n\nflow cytometry\, hematological malignancies and epigenetics.
URL:https://ces.b2sg.org/event/unmc-23aug18/
LOCATION:UNMC University of Nebraska Medical Center\, 42nd and Emile\, Omaha\, NE\, 68198\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/08/unmc-nebraska-med-cent-e1535006544430.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180824
DTEND;VALUE=DATE:20180926
DTSTAMP:20180824T104300Z
CREATED:20180824T104300Z
LAST-MODIFIED:20180824T104300Z
UID:20566-1535068800-1537919999@ces.b2sg.org
SUMMARY:Postdoctoral Research Associates
DESCRIPTION:Multiple Postdoctoral Research Associate positions are immediately available in the laboratory of Dr. Jinghui Zhang\, chair of the Department of Computational Biology. We are seeking highly motivated and creative candidates to lead the discovery and/or methods development in the following areas: a) non-coding driver variants that affect gene regulation in the context of predisposition\, initiation\, and progression of pediatric cancer; b) clonal evolution of relapsed cancer; and c) genomic cloud\, clinical data integration and visualization. The candidates will have access to the large collection of genomic and epigenetic data generated from pediatric cancer patients\, 3D genome technology such as Hi-C/Capture C\, long-read sequencing platform\, and state-of-art visualization tools. The successful candidate will have a strong interest in quantitative data analysis or data visualization with formal training in one of the following areas: genomics\, bioinformatics\, computer science\, genetics\, or cancer biology. Computer programming skills are preferred and interest or experience in genome analysis is a plus. \nSuccessful candidates are expected to excel at critical thinking\, be quick learners for new analytical approaches\, and capable of applying or developing novel computational methods for solving complex problems. Candidates must have a doctoral degree (PhD or MD)\, an excellent publication record\, interest in computational analysis\, and great communication skills. The lab will provide working experience for a fellow who is interested in leading or participating in all aspects of cancer omics studies via multi-disciplinary teamwork. Each fellow will have opportunities to interact with leaders in the fields of pediatric cancer\, epigenetics and translational research within and outside the institution. Inter-disciplinary training will be provided to broaden or strengthen computational or biological expertise. \nInterested applicants are encouraged to apply at https://bit.ly/2NaJdaN \nRecognized as a world leader of genomic research in pediatric cancer\, the Zhang lab has led the characterization of the genomic landscape for over 20 subtypes of pediatric cancers with high-impact publications in Nature\, Nature Genetics\, Nature Methods\, JAMA\, Cancer Cell\, and NEJM in the last five years. The lab has a well-established track record of developing and publishing novel and high-impact analytical and visualization tools for cancer genomic research. Research in the lab is facilitated by access to the wealth of high-quality data\, St. Jude Genomics Cloud\, state-of-art high performance computing facility\, novel analytical pipelines\, latest genomic assay technology\, and scientific expertise in genomics\, cancer biology\, mathematics\, and computer science.
URL:https://ces.b2sg.org/event/stjude-24aug18/
LOCATION:St. Jude Children’s Hospital\, 262 Danny Thomas Pl\, Memphis\, TN\, 38105\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/stjude.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180825
DTEND;VALUE=DATE:20180829
DTSTAMP:20180503T175527Z
CREATED:20180502T234356Z
LAST-MODIFIED:20180503T175527Z
UID:19985-1535155200-1535500799@ces.b2sg.org
SUMMARY:Transcription and Chromatin
DESCRIPTION:The EMBL Transcription and Chromatin meeting has a long-standing tradition in shaping the field of transcriptional regulation. The meeting brings together leading experts covering all aspects of transcription from cis-regulatory function\, long range regulation\, 3-dimensional looping\, the basal transcriptional machinery\, RNA polymerase regulation and function\, nucleosome positioning\, chromatin modifications\, chromatin remodeling\, and epigenetic inheritance of transcriptional silencing. The meeting contains many talks selected from the abstracts that are interspersed with invited speakers\, discussing the latest breakthroughs in transcriptional regulation. \nThe conference is designed to promote interactive discussions at both the talks and poster sessions. Given the excellent line up of speakers and the meeting’s outstanding reputation\, this is a ‘must’ attend for anyone interested in cutting edge research in transcription. \nSession Topics\n\nActivators\, enhancer function\, evolution and modelling\nLong range transcriptional regulation and enhancers\nGeneral basal transcriptional machinery\nPol II function\, pausing and the role of RNA in transcription\nChromatin modifications and transcription\nTranscriptional regulation during cell fate decisions – stem cell reprogramming and normal embryonic development\nGenome topology and three-dimensional regulation\nSingle cell quantification \n\nDEADLINES: \nRegistration – 16 Jul 2018 \nAbstract – 27 Jun 2018
URL:https://ces.b2sg.org/event/embl-25aug18/
LOCATION:EMBL Heidelberg\, Meyerhofstraße 1\, Heidelberg\, 69117 \, Germany
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/EMBL-logo--e1525286945880.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180826
DTEND;VALUE=DATE:20180928
DTSTAMP:20180826T122035Z
CREATED:20180826T122035Z
LAST-MODIFIED:20180826T122035Z
UID:20577-1535241600-1538092799@ces.b2sg.org
SUMMARY:Postdoctoral Scientist
DESCRIPTION:A Postdoctoral Scientist position is available for a skilled and motivated scientist in the Laboratory of Dr. Maho Shibata in the Department of Anatomy and Cell Biology and the Cancer Center at the George Washington University School of Medicine and Health Sciences. \nDr. Shibata’s lab applies concepts from developmental biology and stem cell biology to prostate cancer research. The lab uses genetically engineered mouse models\, explant cultures\, and 3D organoid culture systems to study androgen signaling during prostate development\, and to identify novel molecular drivers of castration-resistant prostate cancer. There are multiple project possibilities. \nDuties include: \n\nIndependently design experiments\, collect and analyze data\, and assist collaborators\nPresent findings in group meetings and internal and external scientific meetings\nPrepare and submit postdoctoral fellowship applications\nWrite and publish research manuscripts\nSupervise and train students\nPerform other duties as assigned. The omission of specific duties does not preclude the supervisor from assigning duties that are logically related to the position.\n\n\nMinimum Qualifications: \nQualified candidates will hold a PhD in a related discipline. Degree must be conferred by the start date of the position. \nAdditional Required Licenses/Certifications/Posting Specific Minimum Qualifications: Preferred Qualifications: \nPhD experience in one or more of the following: cancer biology\, mouse development\, mouse genetics\, stem cell biology\, epigenetics\, computational biology\nAt least 1 first author peer-reviewed publication
URL:https://ces.b2sg.org/event/gwu-26aug18/
LOCATION:George Washington University\, 2121 I St NW\, Washington\, DC\, 20052\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/gwu-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180902
DTEND;VALUE=DATE:20181004
DTSTAMP:20180903T004655Z
CREATED:20180903T004432Z
LAST-MODIFIED:20180903T004655Z
UID:20591-1535846400-1538611199@ces.b2sg.org
SUMMARY:Postdoctoral Research Fellow
DESCRIPTION:The Hackensack Meridian Health Center for Discovery and Innovation is offering a position for postdoctoral studies in the field of cancer signaling and gene expression in the laboratory of Dr. Byungwoo Ryu.  The goal of the laboratory’s research program is to unravel the cancer epigenome regulating mechanisms which can be targeted for the sensitization to the precision therapies in the hope of translating these therapeutic modalities to have long-term clinical benefit. The Ryu laboratory focuses on investigating chromatin remodeling enzymes\, such as histone and DNA modifiers and gene transcription factors as potential targets for overcoming the resistance of oncogene-targeting therapies and enhancing the objective therapy response rate of immune check-point blockade therapies.  The Ryu laboratory uses chemical genetics approaches including small molecule inhibitors\, genome/epigenome-wide profiling\, gene-editing technology\, and animal models. Successful postdoctoral candidate will have a strong interest in cancer biology\, epigenetics\, and immuno-oncology.  The candidate will perform in vivo animal models and in vitro analyses. The postdoctoral fellow is expected to understand the project and work independently taking responsibilities in the development and execution of experimental procedures to successfully advance the research project. The successful candidate will be responsible for preparing data for presentations\, progress reports\, and the preparation of manuscripts and posters. The post-doctoral fellow is anticipated to have good communication and writing skills. The successful candidate will have a team-oriented mindset and will provide guidance to junior members. \n  \n\n\n\nResponsibilities\n\n\n\n\nProficient at most gold standard assays in molecular biology and genetics.\nDesign and conduct animal studies using a vast array of genetic models.\nPerform data analysis and interpretation.\nPresent results in internal and external research forums.\nParticipate in grant and manuscript writing\, as appropriate.\n\n\n\n\nQualifications\n\n\n\n\n\nKnowledge\, Education and Skills Required: \n  \n\nHold a Ph.D. in Molecular Biology\, Biochemistry\, Cancer biology or equivalent from an accredited graduate level institution.\nMinimum publication or in preparation of one article as first author in a reputable peer-reviewed scientific journal.\nExcellent analytical and presentation skills.\nExpertise in cell culture\, flow cytometry\, mouse handling\, and basic cellular and molecular biology techniques required.\n\n  \nKnowledge\, Education and Skills Preferred: \n  \n\nKnowledge and experience with RNA/DNA extraction\, PCR and qPCR analysis\, and next generation sequencing/bioinformatics a plus.
URL:https://ces.b2sg.org/event/hmh-2sept18/
LOCATION:Hackensack University Medical Center\, 30 Prospect Ave\, Hackensack\, NJ\, 07601\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/11/Hackensack-University-Medical-Center.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180903
DTEND;VALUE=DATE:20181005
DTSTAMP:20180903T154215Z
CREATED:20180903T154140Z
LAST-MODIFIED:20180903T154215Z
UID:20596-1535932800-1538697599@ces.b2sg.org
SUMMARY:Population Scientist Positions
DESCRIPTION:The University of New Mexico National Cancer Institute (NCI) Designated Comprehensive Cancer Center (UNMCCC) and the Department of Internal Medicine\, Division of Epidemiology\, Biostatistics\, and Preventive Medicine at the UNM School of Medicine are seeking population scientists with expertise in population-based molecular and/or genetic epidemiology to expand programmatic efforts in cancer control and population science in New Mexico. While these are open rank\, tenure track positions\, we seek highly interactive population scientists with active or developing externally funded research programs and a high degree of academic accomplishments. Selected candidates will have the opportunity to work collaboratively across multiple scientific and clinical oncology disciplines. We are particularly seeking epidemiologists in the areas of genomics\, epigenetics\, gene-environment interactions\, and genetic ancestry and genetic risk assessment. Numerous opportunities are available for translating laboratory-based approaches to improvements in screening\, diagnosis and treatment of several cancers for which New Mexican’s suffer significant cancer health disparities\, including cancers of the breast\, gynecologic malignancies\, hematologic malignancies\, and cancers of the gastrointestinal\, hepatobiliary\, and genitourinary systems. Preference will be given to candidates whose research incorporates biological specimens and employs and develops laboratory-based genetic/genomic measures of risk. Experience with collecting and integrating genomics/genetics\, patient electronic health records and population-based research data to address health disparities is highly desirable. The UNMCCC has substantial opportunities for energetic multidisciplinary collaborations in a highly collegial environment with potential for growth; applicants may have a laboratory-based program and may utilize an extensive array of UNMCCC Shared Resources. The UNMCCC also houses or supports many additional registries and resources\, including the NCI SEER New Mexico Tumor Registry\, the New Mexico Human Papillomavirus (HPV) Registry\, and the Center for Native American Environmental Health Equity. The UNMCCC is also a member of the ORIEN National Cancer Precision Medicine Network of NCI Cancer Centers engaged in cancer sequencing\, precision oncology\, data sharing\, cancer clinical trials and collaborative research (http://oriencancer.org/). Significant resources\, including excellent salaries\, comprehensive start-up packages\, and potential for an endowed position\, are available. \n\n\n\n\n\n\nQualifications\n\nMinimum Qualifications: \n\nPhD in epidemiology or a related field\nPostdoctoral training in molecular or genetic epidemiology\nA track record of relevant scholarly achievement\, including peer-reviewed funding and high quality publications focused on cancer\nEligibility to work in the United States\, (this is not a J-1 visa opportunity.)\n\nPreferred Qualifications: \n\nInterest or expertise in cancer disparities research;\nExpertise in primary data collection with human populations;\nLaboratory–based genetic/genomic methods related to cancer in humans;\nAll outstanding candidates applying molecular or genetic epidemiologic methods to the study of cancer will be considered. Successful candidates will have a joint appointment in a UNM School of Medicine Department and the UNMCCC.
URL:https://ces.b2sg.org/event/unm-3sept18/
LOCATION:The University of New Mexico Comprehensive Cancer Center\, 1201 Camino de Salud\, Albuquerque\, NM\, 87106\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/06/unm-e1496496222390.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180904
DTEND;VALUE=DATE:20181006
DTSTAMP:20180904T135848Z
CREATED:20180904T135848Z
LAST-MODIFIED:20180904T135848Z
UID:20599-1536019200-1538783999@ces.b2sg.org
SUMMARY:Postdoctoral Fellow
DESCRIPTION:Post Doctoral Fellow positions are available in the laboratory of Dr. Matthew Weitzman\, at the Children’s Hospital of Philadelphia (CHOP) and the University of Pennsylvania (Penn). Our lab is part of the rich scientific environment on the CHOP/Penn campus that includes multiple areas of virology\, immunology\, cancer\, and epigenetics. We are located in the new Colket Translational Research Building as part of the Division of Cancer Pathobiology\, in the Department of Pathology & Laboratory Medicine. The lab is also part of the Center for Childhood Cancer Research (CCCR)\, the Center for Cellular & Molecular Therapeutics (CCMT)\, the Penn Institute for Immunology (IFI)\, the Penn Epigenetics program\, and Penn Center for AIDS Research (CFAR). \nThe lab’s research focuses on virus-host interactions and the use of viruses as model systems to study DNA repair\, signaling\, cell biology\, replication\, innate host defenses and gene delivery. We are interested in virus replication and the resulting cellular responses. We study the intersection of virus and host pathways during infection and how they reveal insights into fundamental cellular mechanisms. We are particularly interested in recognition and processing of viral genomes by DNA repair and APOBEC pathways. We are using virus systems to study signaling\, ubiquitination and degradation\, and transcriptional silencing. Viral model systems include adeno-associated virus (AAV)\, adenovirus (Ad) and herpes simplex virus (HSV). \n\nJob Responsibilities \n\n\nConduct independent scholarly research and develop new methods and protocols\nParticipate in project planning\, recording and evaluation of data\nAcquire technical\, lab management and grant writing skills\nParticipate in seminars\, lectures\, poster sessions and presentation at national meetings\nSupervise junior lab members\nAssist with other research projects\n\n\nRequired Education and Experience \n\n\nA terminal degree PhD\, MD\, DVM\, etc.\nAccording to the CMS (Centers for Medicaid and Medicare Services) a copy of diploma or transcript is required as proof of academic achievement for all non-laboratory personnel performing non-waived POC testing\n\n\nPreferred Education\, Experience & Cert/Lic \n\nThe successful applicant will become part of a highly interactive and collaborative team. Applicants must have a Doctoral degree in a related discipline with good skills in molecular biology\, biochemistry and cell biology\, and a strong motivation to learn new techniques and research topics. A background in virology and/or DNA repair would be advantageous. It is expected that this individual will conduct independent scholarly research\, and will contribute to the overall research goals of the project and the research group.
URL:https://ces.b2sg.org/event/chop-4sept18/
LOCATION:Children’s Hospital of Philadelphia\, 3401 Civic Center Blvd\, Philadelphia\, PA\, 19104\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/07/chop-childrens-philadelphia.jpg
END:VEVENT
END:VCALENDAR